60 F
Fort Worth
Monday, October 19, 2020
Health Care Alcon introduces first FDA-approved trifocal lens for cataracts

Alcon introduces first FDA-approved trifocal lens for cataracts

Other News

Exxon’s oil slick

Exxon Mobil is slashing its capital spending budget for 2020 by 30% due to weak demand caused by the COVID-19 pandemic and a market...

Folk music’s Mark Twain: 7 Essential tracks from John Prine,

NEW YORK (AP) — Some people, the songs just come out of them. For nearly half a century, they tumbled out of John Prine...

Tarrant County records another COVID-19 death

Tarrant County Public Health (TCPH) on Wednesday, April 8 reported that a resident of Euless has died as the result of the COVID-19 virus....

Tradition stymied: A year unlike any since WWII for Augusta

The Masters is so intertwined with Augusta, they added an extra day to spring break.You see, the first full week of April isn't just...

Fort Worth-basded Alcon announced Aug. 27 its initial commercial launch and Food and Drug Administration  approval of the first trifocal lens for U.S. patients undergoing cataract surgery.

The PanOptix lens is clinically shown to deliver an exceptional combination of near, intermediate and distance vision while significantly reducing the need for glasses after surgery, Alcon said in a news release.

PanOptix is already one of the leading presbyopia-correcting intraocular lenses in more than 70 countries and is designed for today’s active lifestyles, from viewing mobile devices and computer screens to high-quality distance vision in a range of lighting conditions, the release said.

Presbyopia is the gradual loss of the ability to focus on nearby objects and is a natural, often annoying part of aging, according to the Mayo Clinic.

More than 4 million cataract surgeries are performed each year in the U.S., the Alcon release says, and that number is projected to increase by more than 16 percent by the end of 2024. The presbyopia-correcting IOL market is expected to grow 60 percent by the end of 2024, Alcon said.

“The U.S. ophthalmology community has been eagerly awaiting FDA approval of PanOptix. While participating in the clinical trial, I saw first-hand the impact of this lens on my patients,” Kerry Solomon, M.D., Carolina Eye care Physicians and a PanOptix clinical trial investigator, said in the Alcon release.

A cataract is a cloudy area in the natural lens of the eye that affects vision. As a cataract develops, the eye’s lens gradually becomes hard and cloudy allowing less light to pass through, which makes it more difficult to see, Alcon said.

The vast majority of cataracts result from normal aging, but radiation exposure, taking steroids, diabetes and eye trauma can accelerate their development. Cataracts are the most common age-related eye condition and the leading cause of preventable blindness.

Twenty million people in the U.S. age 40 and older have cataracts. Cataracts are treated by removing the eye’s cloudy natural lens and surgically replacing it with an intraocular lens or IOL. More than 98 percent of cataract surgeries are considered successful, and patients typically can return to their normal routines within 24 hours.

Latest News

Tarrant County reports 4 COVID deaths as Abbott sends team to Panhandle as cases mount

Tarrant County Public Health on Saturday, Oct. 17 reported four COVID-19 deaths. The deceased include a woman from Southlake in her...

Tarrant County reports one COVID death on Friday

Tarrant County Public Health on Friday, Oct. 16 reported one COVID-19 death. The deceased was a man from Arlington in his 70s....

Coronavirus hospitalizations are up in Texas as some fear the state is headed toward another surge

By Shannon Najmabadi and Edgar Walters, The Texas Tribune Oct. 16, 2020 "Coronavirus hospitalizations are up in Texas as...

Tarrant County reports 2 COVID deaths

Tarrant County Public Health on Oct. 15 reported two COVID-19 deaths. The deceased include a man from Arlington in his 90s and...

US regulators approve 1st treatment for Ebola virus

By LINDA A. JOHNSON AP Medical WriterU.S. regulators Wednesday approved the first drug for the treatment of Ebola.The Food and Drug Administration...